Saturday, February 21, 2026
19.1 C
Bengaluru

Anup Soans

Reach out to Anup Soans: anupsoans@medicinman.net.

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy of the world” — supplying affordable generics globally. But the...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals of Indian FMCG, the ₹5 snack SKU is a masterclass...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity rates are increasing, and CPAP adoption remains minimal, a pill...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends globally. When a gene therapy corrects a rare mutation, headlines...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one side: alarm over rising surgical deliveries.On the other: defensive reactions...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They are signals. Sanofi’s decision not to renew Paul Hudson’s mandate as...
spot_imgspot_img

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO roots, bought a Sanofi icon, and became the hottest target...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in Cancer Care India’s pharmaceutical success has long rested on speed, scale,...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic...

Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point

In an earlier article in The Wire Science, I argued that India’s debate on generic medicines is routinely misframed....

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR Dec 2025 report with the previously reviewed PharmaTrac Dec 2025...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a compelling snapshot of the Indian Pharmaceutical Market (IPM) at a...